January 16, 2024 05:46 pm | Updated 07:04 pm IST - HYDERABADWorld Health Organisation (WHO) has granted emergency use listing (EUL) for Corbevax, the Covid vaccine developed by Hyderabad-based vaccine maker Biological E.India’s first indigenously developed Covid-19 vaccine based on protein sub-unit platform, Corbevax formed a part of the arsenal in the country’s fight against the deadly virus. Next-gen vaccineBE said it is working on a next-generation Covid-19 vaccine that is based on the XBB1.5 variant of the SARS-CoV-2 virus. It would conform to the recommendations of WHO TAG-CO-VAC, the technical advisory group on Covid-19 vaccine composition. The company recently received final approval from CDSCO to begin clinical trials of the XBB.1.5 variant vaccine in India. BE has already qualified manufacturing infrastructure for producing variant vaccines to initiate supply at a short notice, it said.

Source: The Hindu January 17, 2024 02:34 UTC